Ingénieur d'étudeMise à jour le 18/02/2022
Brevets / Publications / Communications
2021
Choudhary BS, Sukanya, Mehta P, Bach S, Ruchaud S, Robert T, Josselin B, Filipek S, Malik R. Discovery of thiazolidin-4-one analogue as selective GSK-3β inhibitor through structure based virtual screening. Bioorg Med Chem Lett. 2021 Nov 15;52:128375. doi: 10.1016/j.bmcl.2021.128375.
Juillet C,
Ermolenko L, Boyarskaya D, Baratte B, Josselin B, Nedev H, Bach S, Iorga
BI, Bignon J, Ruchaud S, Al-Mourabit A. From Synthetic Simplified Marine
Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase. J
Med Chem. 2021 Jan 28;64(2):1197-1219. doi: 10.1021/acs.jmedchem.0c02064.
2020
Elie J, Feizbakhsh O, Desban N, Josselin B, Baratte B, Bescond A, Duez J, Fant X, Bach S, Marie D, Place M, Ben Salah S, Chartier A, Berteina-Raboin S, Chaikuad A, Knapp S, Carles F, Bonnet P, Buron F, Routier S, Ruchaud S. Design of new disubstituted imidazo[1,2-b]pyridazine derivatives as selective Haspin inhibitors. Synthesis, binding mode and anticancer biological evaluation. J Enzyme Inhib Med Chem. 2020 Dec;35(1):1840-1853. doi: 10.1080/14756366.2020.1825408.
Benchekroun
M, Ermolenko L, Tran MQ, Vagneux A, Nedev H, Delehouzé C, Souab M, Baratte B, Josselin
B, Iorga BI, Ruchaud S, Bach S, Al-Mourabit A. Discovery of simplified
benzazole fragments derived from the marine benzosceptrin B as necroptosis
inhibitors involving the receptor interacting protein Kinase-1. Eur J Med Chem.
2020 Sep 1;201:112337. doi: 10.1016/j.ejmech.2020.112337.
Qhobosheane
MA, Legoabe LJ, Josselin B, Bach S, Ruchaud S, Beteck RM. Synthesis and
evaluation of C3 substituted chalcone-based derivatives of 7-azaindole as
protein kinase inhibitors. Chem Biol Drug Des. 2020 Dec;96(6):1395-1407. doi:
10.1111/cbdd.13748.
Ibrahim N,
Bonnet P, Brion JD, Peyrat JF, Bignon J, Levaique H, Josselin B, Robert
T, Colas P, Bach S, Messaoudi S, Alami M, Hamze A. Identification of a new
series of flavopiridol-like structures as kinase inhibitors with high cytotoxic
potency. Eur J Med Chem. 2020 Aug 1;199:112355. doi:
10.1016/j.ejmech.2020.112355.
Qhobosheane
MA, Legoabe LJ, Josselin B, Bach S, Ruchaud S, Petzer JP, Beteck RM. Synthesis
and evaluation of 7-azaindole derivatives bearing benzocycloalkanone motifs as
protein kinase inhibitors. Bioorg Med Chem. 2020 Jun 1;28(11):115468. doi:
10.1016/j.bmc.2020.115468.
2019
Zeinyeh W,
Esvan YJ, Josselin B, Baratte B, Bach S, Nauton L, Théry V, Ruchaud S,
Anizon F, Giraud F, Moreau P. Kinase inhibitions in pyrido[4,3-h] and
[3,4-g]quinazolines: Synthesis, SAR and molecular modeling studies. Bioorg Med
Chem. 2019 May 15;27(10):2083-2089. doi: 10.1016/j.bmc.2019.04.005.
Oukoloff K,
Coquelle N, Bartolini M, Naldi M, Le Guevel R, Bach S, Josselin B,
Ruchaud S, Catto M, Pisani L, Denora N, Iacobazzi RM, Silman I, Sussman JL,
Buron F, Colletier JP, Jean L, Routier S, Renard PY. Design, biological
evaluation and X-ray crystallography of nanomolar multifunctional ligands
targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3. Eur
J Med Chem. 2019 Apr 15;168:58-77. doi: 10.1016/j.ejmech.2018.12.063.
Tazarki H,
Zeinyeh W, Esvan YJ, Knapp S, Chatterjee D, Schröder M, Joerger AC, Khiari J, Josselin
B, Baratte B, Bach S, Ruchaud S, Anizon F, Giraud F, Moreau P. New
pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis,
biological evaluation and binding mode analysis. Eur J Med Chem. 2019 Mar
15;166:304-317. doi: 10.1016/j.ejmech.2019.01.052.
Motuhi SE,
Feizbakhsh O, Foll-Josselin B, Baratte B, Delehouzé C, Cousseau A, Fant
X, Bulinski JC, Payri CE, Ruchaud S, Mehiri M, Bach S. Neurymenolide A, a Novel
Mitotic Spindle Poison from the New Caledonian Rhodophyta Phacelocarpus
neurymenioides. Mar Drugs. 2019 Feb 1;17(2):93. doi: 10.3390/md17020093.
Masłyk M,
Janeczko M, Martyna A, Czernik S, Tokarska-Rodak M, Chwedczuk M, Foll-Josselin
B, Ruchaud S, Bach S, Demchuk OM, Kubiński K. The Anti-Candida albicans
Agent 4-AN Inhibits Multiple Protein Kinases. Molecules. 2019 Jan 2;24(1):153. doi:
10.3390/molecules24010153.